(DBPD) Xtrackers ShortDAX x2 Daily - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0411075020

Daily, Short, Futures, Swaps, Derivatives, Equity, Index

Description: DBPD Xtrackers ShortDAX x2 Daily

The Xtrackers ShortDAX x2 Daily Swap UCITS ETF1C (XETRA:DBPD) is a leveraged inverse equity ETF that allows investors to profit from a decline in the DAX index. It achieves this by providing twice the inverse daily return of the DAX index, making it a high-risk, high-reward investment vehicle.

From a technical analysis perspective, the ETFs current price of 0.56 is below its 20-day, 50-day, and 200-day simple moving averages (SMA20: 0.61, SMA50: 0.63, SMA200: 0.77), indicating a bearish trend. The Average True Range (ATR) of 0.03, or 5.84% of the current price, suggests a relatively high level of volatility. Given the current price is near the 52-week low of 0.55, a potential support level, and considering the ETFs purpose is to inversely track the DAX index, we can infer that the DAX index has likely been rising. A forecast based on the technical data suggests that if the DAX continues to rise, DBPD may continue to decline, potentially testing its 52-week low.

Fundamentally, the ETF has Assets Under Management (AUM) of 132.01M EUR, indicating a moderate level of investor interest. Leveraged and inverse ETFs like DBPD are typically used for short-term trading strategies rather than long-term investments. They are designed to meet their investment objectives on a daily basis, and their performance over longer periods can deviate significantly from their stated objectives due to compounding effects.

Combining both technical and fundamental analysis, a potential forecast is that if the DAX index continues its upward trend, DBPD may see further decline. However, if theres a significant downturn in the DAX, DBPD could potentially rise. Investors should be cautious and closely monitor the DAX index, as well as the ETFs technical indicators, to make informed decisions. The high volatility and leveraged nature of DBPD make it unsuitable for risk-averse investors or those with a long-term investment horizon.

Additional Sources for DBPD ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

DBPD ETF Overview

Market Cap in USD 155m
Category Trading - Leveraged/Inverse Equity
TER 0.60%
IPO / Inception 2010-03-18

DBPD ETF Ratings

Growth Rating -91.7
Fundamental -
Dividend Rating 0.0
Rel. Strength -56.8
Analysts -
Fair Price Momentum 0.37 EUR
Fair Price DCF -

DBPD Dividends

Currently no dividends paid

DBPD Growth Ratios

Growth Correlation 3m -62.6%
Growth Correlation 12m -95.7%
Growth Correlation 5y -92.7%
CAGR 5y -25.99%
CAGR/Max DD 5y -0.32
Sharpe Ratio 12m -2.57
Alpha -35.75
Beta -1.185
Volatility 24.68%
Current Volume 3280.3k
Average Volume 20d 3355.7k
Stop Loss 0.5 (-3.8%)
What is the price of DBPD shares?
As of July 12, 2025, the stock is trading at EUR 0.52 with a total of 3,280,296 shares traded.
Over the past week, the price has changed by -4.30%, over one month by -3.69%, over three months by -29.44% and over the past year by -42.94%.
Is Xtrackers ShortDAX x2 Daily a good stock to buy?
No, based on ValueRay´s Analyses, Xtrackers ShortDAX x2 Daily (XETRA:DBPD) is currently (July 2025) a stock to sell. It has a ValueRay Growth Rating of -91.74 and therefor a clear technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DBPD is around 0.37 EUR . This means that DBPD is currently overvalued and has a potential downside of -28.85%.
Is DBPD a buy, sell or hold?
Xtrackers ShortDAX x2 Daily has no consensus analysts rating.
What are the forecasts for DBPD share price target?
According to our own proprietary Forecast Model, DBPD Xtrackers ShortDAX x2 Daily will be worth about 0.4 in July 2026. The stock is currently trading at 0.52. This means that the stock has a potential downside of -23.08%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 0.4 -23.1%